About ABO Diag SAS
ABO Diag SAS is a company based in Martillac (France) founded in 2008 was acquired by Diagast in March 2014. ABO Diag SAS has raised $600.82 thousand across 1 funding round from investors including Diagast and Succes Europe. ABO Diag SAS operates in a competitive market with competitors including Hemcheck, Epocal, Daxor, Cellmic and Essenlix, among others.
- Headquarter Martillac, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ABO Diag SAS
ABO Diag SAS has successfully raised a total of $600.82K through 1 strategic funding round. The most recent funding activity was a Seed round of $600.82 thousand completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ABO Diag SAS
ABO Diag SAS has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Diagast and Succes Europe.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Products and services for blood transfusion are developed and marketed.
|
Locked | Locked | Locked |
Investor details for ABO Diag SAS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ABO Diag SAS
Investment portfolio details for ABO Diag SAS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ABO Diag SAS
Detailed financials for ABO Diag SAS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abo Diag Sas Comparisons
Peer comparison for ABO Diag SAS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ABO Diag SAS
ABO Diag SAS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemcheck, Epocal, Daxor, Cellmic and Essenlix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| Locked | Locked | Locked |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| Locked | Locked | Locked |
Blood volume analyzers are developed by Daxor for diagnostic applications.
|
|
| Locked | Locked | Locked |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| Locked | Locked | Locked |
Mobile health self-test platform is provided using nanotechnology and AI.
|
|
| Locked | Locked | Locked |
Develops a hand-held blood test device from a single drop of blood.
|
Detailed competitors of ABO Diag SAS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abo Diag Sas
Complete news archive for ABO Diag SAS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABO Diag SAS
ABO Diag SAS was founded in 2008 and raised its 1st funding round 5 years after it was founded.
ABO Diag SAS is headquartered in Martillac, France. It is registered at Martillac, Gironde, France.
ABO Diag SAS is a funded company, having raised a total of $600.82K across 1 funding round to date.
ABO Diag SAS was founded in 2008 and is based in Martillac, France. Blood analyzers are manufactured and marketed by the company within the medical diagnostics sector. Blood reagents are provided alongside the ABTest Card assay, which relies on antibodies (anti-A and anti-B) fixed covalently onto layered membranes for blood group testing. Operations focus on diagnostic tools for healthcare applications.
ABO Diag SAS's top competitors include Daxor, Pathshodh Healthcare and Cellmic.
ABO Diag SAS has 2 investors. Key investors include Diagast, and Succes Europe.